Weight-loss pill passes important safety trial

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing “encouraging data” out of its Phase I study of its obesity and diabetes drug AZD5004.Continue ReadingC…

Alzheimer’s drug trial raises concerns for accelerating cognitive decline

A drug that reduces iron levels in the brain also has a profound effect on Alzheimer's disease progression

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new research investigating the effects of an available iron-reducing drug has raised concerns about its use as a treatment for the condition.

Continue Reading

Category: Alzheimer’s & Dementia, Brain Health, Body & Mind

Tags: , ,